NCT04619836View on ClinicalTrials.gov

Cost-effectiveness of the Care Pathways

Enrolling by invitationOBSERVATIONAL

Enrollment

2,500

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2035

Conditions

Diabete Type 2Substance Abuse

Trial Locations (1)

33521

Tampere university hospital, Tampere

All Listed Sponsors

collaborator

Tampere University

OTHER

lead

Tampere University Hospital

OTHER